Skip to main content
OpenTrials

Clinical trial condition

Liver Cirrhosis, Biliary

Explore clinical trials studying Liver Cirrhosis, Biliary. Study availability and eligibility vary by location and protocol.

152 public trials 32 recruiting studies
Refine in advanced search Browse all conditions

Liver Cirrhosis, Biliary trial results

Completed

Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid

NCT03124108

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Mayo Clinic in Arizona Phoenix, Arizona, United States
  • Schiff Center for Liver Diseases Miami, Florida, United States
  • Cleveland Clinic Florida Weston, Florida, United States
  • Piedmont Research Institute Atlanta, Georgia, United States
View all 24 locations
View Trial Details
Completed

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis

NCT01904058

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +10 more
Locations
  • Scripps Clinic La Jolla, California, United States
  • University of California at Davis Sacramento, California, United States
  • University of Miami Miami, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View all 24 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus

NCT01899703

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +13 more
Locations
  • GSK Investigational Site Birmingham, West Midlands, United Kingdom
  • GSK Investigational Site Cambridge, United Kingdom
  • GSK Investigational Site Newcastle upon Tyne, United Kingdom
View Trial Details

Related conditions